First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

被引:60
作者
Galeva, S. [1 ,2 ]
Gil, M. M. [1 ,3 ,4 ]
Konstantinidou, L. [1 ]
Akolekar, R. [2 ,5 ]
Nicolaides, K. H. [1 ]
机构
[1] Kings Coll Hosp London, Fetal Med Res Inst, 16-20 Windsor Walk,Denmark Hill, London SE5 8BB, England
[2] Medway Maritime Hosp, Dept Fetal Med, Gillingham, Kent, England
[3] Univ Francisco Vitoria, Sch Hlth Sci, Madrid, Spain
[4] Hosp Univ Torrejon, Obstet & Gynecol Dept, Madrid, Spain
[5] Canterbury Christ Church Univ, Inst Med Sci, Chatham, Kent, England
关键词
cell-free DNA; fetal fraction; first-trimester screening; non-invasive prenatal testing; trisomy; 13; 18; 21; twin pregnancy; CELL-FREE DNA; WEEKS GESTATION RELATION; 1ST TRIMESTER; DOWN-SYNDROME; FETAL; IMPLEMENTATION; ANEUPLOIDIES; IMPACT;
D O I
10.1002/uog.20290
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To examine factors affecting the rate of failure to obtain a result from cell-free DNA (cfDNA) testing of maternal blood for fetal trisomies 21, 18 and 13 in singleton and twin pregnancies in the first trimester. Methods This was a prospective study of 23 495 singleton and 928 twin pregnancies undergoing screening for fetal trisomy by targeted cfDNA testing at 10+0 to 14+1 weeks' gestation. Multivariate logistic regression analysis was used to determine significant predictors of failure to obtain a result after first sampling. Results There was no result from cfDNA testing after first sampling in 3.4% (798/23 495) of singletons, 11.3% (91/806) of dichorionic twins and 4.9% (6/122) of monochorionic twins. Multivariate logistic regression analysis demonstrated that the risk of test failure, first, increased with increasing maternal age (odds ratio (OR), 1.02; 95% CI, 1.01-1.04) and weight (OR, 1.05; 95% CI, 1.04-1.05), decreasing gestational age (OR, 0.85; 95% CI, 0.79-0.91), serum pregnancy-associated plasma protein-A (PAPP-A) multiples of the median (MoM) (OR, 0.56; 95% CI, 0.49-0.65) and free beta-human chorionic gonadotropin (beta-hCG) MoM (OR, 0.67; 95% CI, 0.60-0.74), second, was higher in women of black (OR, 1.72; 95% CI, 1.33-2.20) and South Asian (OR, 1.99; 95% CI, 1.56-2.52) than those of white racial origin, in dichorionic twin than in singleton pregnancy (OR, 1.75; 95% CI, 1.34-2.26) and in pregnancies conceived by in-vitro fertilization than in those conceived naturally (OR, 3.82; 95% CI, 3.19-4.55) and, third, was lower in parous than in nulliparous women (OR, 0.63; 95% CI, 0.55-0.74). Conclusions Maternal age, weight, racial origin and parity, gestational age, dichorionicity, method of conception and serum levels of free beta-hCG and PAPP-A are independent predictors of cfDNA test failure. The risk of test failure is higher in dichorionic twin than in singleton pregnancies, mainly because a higher proportion of twins are conceived by in-vitro fertilization and more of the women are nulliparous. Copyright (c) 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 38 条
  • [31] Performance of first-trimester combined test for Down syndrome in different maternal age groups: reason for adjustments in screening policy?
    Engels, Melanie A. J.
    Heijboer, A. C.
    Blankenstein, Marinus A.
    van Vugt, John M. G.
    PRENATAL DIAGNOSIS, 2011, 31 (13) : 1241 - 1245
  • [32] First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies
    Bersinger, NA
    Noble, P
    Nicolaides, KH
    PRENATAL DIAGNOSIS, 2003, 23 (02) : 157 - 162
  • [33] First-trimester Combined Screening Test for Aneuploidies in Brazilian Unselected Pregnancies: Diagnostic Performance of Fetal Medicine Foundation Algorithm
    Abi Abib, Laila Pinheiro
    Moreira de Sa, Renato Augusto
    Peixoto-Filho, Fernando Maia
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2018, 40 (07): : 384 - 389
  • [34] Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening test
    Blanquet, Marie
    Dreux, Sophie
    Leger, Stephanie
    Sault, Corinne
    Mourgues, Charline
    Laurichesse, Helene
    Lemery, Didier
    Vendittelli, Francoise
    Debost-Legrand, Anne
    Muller, Francoise
    ANNALES DE BIOLOGIE CLINIQUE, 2021, 79 (04) : 331 - 344
  • [35] Screening for trisomy 21 in twin pregnancies in the first trimester:: does chorionicity impact on maternal serum free β-hCG or PAPP-A levels?
    Spencer, K
    PRENATAL DIAGNOSIS, 2001, 21 (09) : 715 - 717
  • [36] Combined test plus inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down Syndrome
    Ramos-Corpas, D. J.
    Santiago, J. C.
    PRENATAL DIAGNOSIS, 2008, 28 (09) : 833 - 838
  • [37] Positive predictive values for detection of trisomies 21, 18 and 13 and termination of pregnancy rates after referral for advanced maternal age, first trimester combined test or ultrasound abnormalities in a national screening programme (2007-2009)
    Siljee, Jacqueline E.
    Knegt, Alida C.
    Knapen, Maarten F. C. M.
    Bekker, Mireille N.
    Visser, Gerard. H. A.
    Schielen, Peter C. J. I.
    PRENATAL DIAGNOSIS, 2014, 34 (03) : 259 - 264
  • [38] Rapid confirmation of maternal origin of trisomy 21 by quantitative fluorescent polymerase chain reaction in a fetus associated with increased nuchal translucency, abnormal first-trimester maternal serum screening result and positive non-invasive prenatal testing for trisomy 21
    Chen, Chih-Ping
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (06): : 953 - 954